Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $3.6M invested in Bio-Rad Laboratories Class B in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
331% more capital invested
Capital invested by funds: $835K → $3.6M (+$2.77M)
50% more funds holding
Funds holding: 4 → 6 (+2)
0.44% more ownership
Funds ownership: 0.14% → 0.58% (+0.44%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$14.7K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$244 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$8.77K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $2.76M | +$2.72M | +22,318 | New |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $768K | – | – | – |
|
|
U
3
UBS
Zurich,
Switzerland
| $66K | +$14.7K | +121 | +29% |
|
4
Invesco
Atlanta,
Georgia
| $6K | – | – | – |
|
|
5
Barclays
London,
United Kingdom
| $2K | -$8.77K | -72 | -81% |
|
|
6
Bank of America
Charlotte,
North Carolina
| – | +$244 | +2 | New |
|
BIO.B Hedge Fund Activity: Q4 2013 in Review
6 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2013, worth a combined $3.6M — up 331% from $835K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIO.B positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS, adding an estimated $14.7K. The largest seller was Barclays, cutting an estimated $8.77K.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2013, up from 4 in Q3 2013.
- Funds reported $3.6M of Bio-Rad Laboratories Class B stock for Q4 2013, up 331% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q4 2013 and 0 closed out, a net change of +2 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2013 was UBS, an estimated $14.7K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2013 was Barclays, an estimated $8.77K sold.
Based on aggregated 13F filings for Q4 2013.